These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 24217550)
1. Benign cystic mesothelioma: false-positive iodine accumulation in a patient with oncocytic follicular thyroid carcinoma. Meyer M; Godbert Y; Soubeyran I; Cazeau AL; Bonichon F Clin Nucl Med; 2014 Sep; 39(9):e395-7. PubMed ID: 24217550 [TBL] [Abstract][Full Text] [Related]
2. Sensitivity of 123I whole-body scan and thyroglobulin in the detection of metastases or recurrent differentiated thyroid cancer. de Geus-Oei LF; Oei HY; Hennemann G; Krenning EP Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):768-74. PubMed ID: 12029550 [TBL] [Abstract][Full Text] [Related]
3. I-131 accumulation in a benign cystic mesothelioma in a patient with follicular thyroid cancer. de Keizer B; Arsos G; Smit JW; Lam MG; Rinkes IH; Goldschmeding R; van Isselt JW Thyroid; 2008 Mar; 18(3):369-71. PubMed ID: 18298317 [TBL] [Abstract][Full Text] [Related]
4. Thallium-201 and iodine-131 scintigraphy in differentiated thyroid carcinoma. Lorberboym M; Murthy S; Mechanick JI; Bergman D; Morris JC; Kim CK J Nucl Med; 1996 Sep; 37(9):1487-91. PubMed ID: 8790199 [TBL] [Abstract][Full Text] [Related]
5. Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma. Gallowitsch HJ; Mikosch P; Kresnik E; Unterweger O; Gomez I; Lind P J Nucl Med; 1998 May; 39(5):870-5. PubMed ID: 9591591 [TBL] [Abstract][Full Text] [Related]
6. [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography localizes residual thyroid cancer in patients with negative diagnostic (131)I whole body scans and elevated serum thyroglobulin levels. Wang W; Macapinlac H; Larson SM; Yeh SD; Akhurst T; Finn RD; Rosai J; Robbins RJ J Clin Endocrinol Metab; 1999 Jul; 84(7):2291-302. PubMed ID: 10404792 [TBL] [Abstract][Full Text] [Related]
7. Total-body scintigraphy with thallium-201 and iodine-131 in the follow-up of differentiated thyroid cancer. Carril JM; Quirce R; Serrano J; Banzo I; Jiménez-Bonilla JF; Tabuenca O; Barquín RG J Nucl Med; 1997 May; 38(5):686-92. PubMed ID: 9170428 [TBL] [Abstract][Full Text] [Related]
8. Hiatus hernia: a potential cause of false-positive iodine-131 scan in thyroid carcinoma. Ho Y; Hicks R Clin Nucl Med; 1998 Sep; 23(9):621-2. PubMed ID: 9735991 [No Abstract] [Full Text] [Related]
9. Nuclear medicine approaches in the monitoring of thyroid cancer patients. Sergieva S; Hadjieva T; Doldurova M; Stefanova S; Dudov A J BUON; 2006; 11(4):511-8. PubMed ID: 17309186 [TBL] [Abstract][Full Text] [Related]
10. False-positive I-131 images mimicking thyroid cancer metastasis. The nose ring sign. Dick C; Mudun A; Alazraki NP Clin Nucl Med; 1995 Oct; 20(10):876-7. PubMed ID: 8616990 [TBL] [Abstract][Full Text] [Related]
11. [False positive scintigraphic images in the surveillance of differentiated thyroid cancers]. Rudoni S; Toubeau M; Mansuy S; Vaillant G; Verges B; Brun JM; Brunotte F Ann Endocrinol (Paris); 1997; 58(5):399-407. PubMed ID: 9685998 [TBL] [Abstract][Full Text] [Related]
12. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy. Lind P; Gallowitsch HJ Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519 [TBL] [Abstract][Full Text] [Related]
13. Could [18]F-fluorodeoxyglucose PET/CT change the therapeutic management of stage IV thyroid cancer with positive (131)I whole body scan? Piccardo A; Foppiani L; Morbelli S; Bianchi P; Barbera F; Biscaldi E; Altrinetti V; Villavecchia G; Cabria M Q J Nucl Med Mol Imaging; 2011 Feb; 55(1):57-65. PubMed ID: 21285923 [TBL] [Abstract][Full Text] [Related]
14. [Patients treated for differentiated thyroid cancer with negative 131I whole-body scans and elevated thyroglobulin levels: a possible course]. Gutiérrez Cardo AL; Rodríguez Rodríguez JR; Borrego Dorado I; Navarro González E; Tirado Hospital JL; Vázquez Albertino R Rev Esp Med Nucl; 2007; 26(3):138-45. PubMed ID: 17524307 [TBL] [Abstract][Full Text] [Related]
15. Thallium-201, technetium-99m-tetrofosmin and iodine-131 in detecting differentiated thyroid carcinoma metastases. Unal S; Menda Y; Adalet I; Boztepe H; Ozbey N; Alagöl F; Cantez S J Nucl Med; 1998 Nov; 39(11):1897-902. PubMed ID: 9829579 [TBL] [Abstract][Full Text] [Related]
16. Is there a role for sandostatin treatment in patients with progressive thyroid cancer and iodine-negative but somatostatin-receptor-positive metastases? Kohlfuerst S; Igerc I; Gallowitsch HJ; Gomez I; Kresnik E; Matschnig S; Lind P Thyroid; 2006 Nov; 16(11):1113-9. PubMed ID: 17123338 [TBL] [Abstract][Full Text] [Related]
17. Clinical value of different responses of serum thyroglobulin to recombinant human thyrotropin in the follow-up of patients with differentiated thyroid carcinoma. David A; Blotta A; Rossi R; Zatelli MC; Bondanelli M; Roti E; Braverman LE; Busutti L; degli Uberti EC Thyroid; 2005 Feb; 15(2):158-64. PubMed ID: 15753676 [TBL] [Abstract][Full Text] [Related]
18. False-positive uptake of 124I in a laryngeal cyst mimicking thyroid remnant after thyroidectomy and 131i therapy for follicular thyroid carcinoma. Noordman BJ; Comans E; Lips P; Rinkel RN Clin Nucl Med; 2014 Oct; 39(10):898-9. PubMed ID: 24561682 [TBL] [Abstract][Full Text] [Related]
19. False-positive I-131 whole-body scan in follicular thyroid carcinoma caused by frontal sinus mucocele. Duque JJ; Miguel MB; Ruiz E; Castillo L; Claver M; Rubio MJ; Calvo JI; Rodriguez A; Zamora B; Casado C Clin Nucl Med; 2000 Feb; 25(2):137-8. PubMed ID: 10656653 [No Abstract] [Full Text] [Related]
20. Metastatic follicular thyroid carcinoma to the thymus in a 35-year-old woman. Nam MS; Chu YC; Choe WS; Kim SJ; Hong SB; Kim YJ; Kim YS Yonsei Med J; 2002 Oct; 43(5):665-9. PubMed ID: 12402382 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]